knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 23:01:15 - browse：45

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

hotspot

WSS

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

ALS treatment from Biogen, Ionis fails in study

WuXi Biologics beefs up its lobbying operation

Boston hospital trains restaurant workers on naloxone for overdoses

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Clinicians often fail to acknowledge the pain caused by long Covid

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What a koala virus tells us about the human genome

Trump demands the U.S. pay no more for drugs than other countries … again

Why we need mandatory labeling of GMO products

Medicare details structure of new drug price negotiation program

Why some fertility treatments produce more boy babies

23andMe had bad news about my health. I wish a person had delivered it

The White House hikes tariffs on plastic syringes made in China

Jerome Adams on the need for new antivirals for Covid

Obesity drug from Roche shows promise in early study

hotspot

Achieving telehealth equity for people with hearing loss

Beyond aggravation: Constipation is an American epidemic

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Louisiana bill approved classifying abortion pills as controlled substances

Decentralized clinical trials need collaboration to achieve wider use

Lilly’s weekly insulin works as well as daily products, new studies show

hotspot

hotspot

hotspot

focus